<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02039479</url>
  </required_header>
  <id_info>
    <org_study_id>01KG1307</org_study_id>
    <nct_id>NCT02039479</nct_id>
  </id_info>
  <brief_title>Randomized, Placebo-controlled Multicenter Trial of Lithium Plus Treatment as Usual (TAU) for Acute Suicidal Ideation and Behavior in Patients With Suicidal Major Depressive Episode</brief_title>
  <official_title>Randomized, Placebo-controlled Multicenter Trial of Lithium Plus Treatment as Usual (TAU) for Acute Suicidal Ideation and Behavior in Patients With Suicidal Major Depressive Episode</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität Dresden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Technische Universität Dresden</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary hypothesis of this confirmatory study is that lithium therapy will acutely
      decrease suicidal ideation and/or suicidal behaviour in inpatients with a major depressive
      episode (MDE, unipolar and bipolar disorder according to DSM IV criteria). The specific aim
      is to test the hypothesis that lithium plus treatment as usual (TAU), compared to placebo
      plus TAU, results in a significantly greater decrease in suicidal ideation and/or behaviour
      over 5 weeks in inpatients with MDE.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will consist of 254 adult patients, hospitalized for a major depressive episode
      with suicidal ideation and/or behaviour who will be randomized to two groups of each 127
      participants. All study participants will receive treatment as usual in the hospital,
      including (psycho)pharmacological treatment and, if needed, psychotherapy plus a 5-week
      course of lithium or placebo. Rating scales will be used daily resp. weekly to measure
      suicidal ideation and/or behaviour, depression, anxiety, mixed/manic features and
      impulsiveness. Experienced clinicians will rate suicidal ideation and/or behaviour as well as
      depression twice a week and anxiety, mixed/manic features and impulsiveness once a week.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>S-STS</measure>
    <time_frame>5 Weeks</time_frame>
    <description>Change in the clinician administered (S-STS=Sheehan Suicidality Tracking Scale) total score between initial and final visit</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>C-SSRS</measure>
    <time_frame>5 weeks</time_frame>
    <description>Change of the total score of C-SSRS (Columbia-Suicide Severity Rating Scale) between start and final visit</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">254</enrollment>
  <condition>Suicidal Ideation/Behavior</condition>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>TAU + Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Treatment as Usual + Placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TAU + Lithium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment as Usual + Lithium</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lithium Carbonate</intervention_name>
    <description>Lithium as Add on to every necessary treatment as usual</description>
    <arm_group_label>TAU + Lithium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo as ADD-on to every necessary treatment as usual</description>
    <arm_group_label>TAU + Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Major depressive episode; inpatient at screening visit; suicidal ideation/behaviour
             present defined by a clinical rating of 8 on the Sheehan Suicidality Tracking Scale
             (S-STS) and a rating of ≥20 on the Montgomery Asberg Depression Scale (MADRS) at both
             screening and baseline visits; both gender, age 18 years.

        Exclusion Criteria:

          -  Contraindication for and history of lithium treatment within the past 6 months;
             patient unable to tolerate lithium treatment in the past; comorbid
             borderline/antisocial personality disorder, currently active substance dependency;
             patients with acute or unstable severe medical conditions, patients unable to
             understand the informed consent or involuntary inpatients, positive toxicology screen
             (illegal drugs), pregnancy and lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Bauer, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Psychiatry and Psychotherapy; TU Dresden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ute Lewitzka, MD</last_name>
    <role>Study Director</role>
    <affiliation>Dept. of Psychiatry and Psychotherapy, TU Dresden</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Bauer, Prof.</last_name>
    <phone>+49 351 458</phone>
    <phone_ext>2760</phone_ext>
    <email>michael.bauer@uniklinikum-dresden.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ute Lewitzka, MD</last_name>
    <phone>+49 351 458</phone>
    <phone_ext>3671</phone_ext>
    <email>ute.lewitzka@uniklinikum-dresden.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dept. of Psychiatry and Psychotherapy, Hospital of Dresden Neustadt</name>
      <address>
        <city>Dresden</city>
        <state>Saxony</state>
        <zip>01324</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Burkhard Jabs, Prof</last_name>
      <phone>+49 351 856 69</phone>
      <phone_ext>02</phone_ext>
      <email>burkhard.jabs@khdh.de</email>
    </contact>
    <investigator>
      <last_name>Burkhard Jabs, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Psychiatrie, Verhaltensmedizin und Psychosomatik</name>
      <address>
        <city>Chemnitz</city>
        <zip>09116</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Barth, MD</last_name>
      <email>t.barth@skc.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinik für Psychiatrie, Psychosomatik und Psychotherapie Universitätsklinikum Frankfurt</name>
      <address>
        <city>Frankfurt am main</city>
        <zip>60528</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Reif, Prof.</last_name>
      <phone>069 / 6301-5222</phone>
      <email>andreas.reif@kgu.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Psychatrie Universitätsmedizin Göttingen</name>
      <address>
        <city>Göttingen</city>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Trost, MD</last_name>
      <email>s.trost@med.uni-goettingen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69115</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oliver Gruber, Prof.</last_name>
      <email>oliver.gruber@med.uni.heidelberg.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 16, 2014</study_first_submitted>
  <study_first_submitted_qc>January 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 17, 2014</study_first_posted>
  <last_update_submitted>March 14, 2018</last_update_submitted>
  <last_update_submitted_qc>March 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>anti-suicide</keyword>
  <keyword>Lithium</keyword>
  <keyword>Depression</keyword>
  <keyword>suicidal Ideation/behavior</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Suicidal Ideation</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lithium Carbonate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

